Who to call at Inovio, and when
Fundz watches for the moments Inovio starts buying, and tells you who to reach.
- An alert the day Inovio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inovio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inovio. With Fundz connected, it knows.
INOVIO Partners with ApolloBio to Submit Regulatory Filing for VGX-3100 Following Successful Phase 3 Trial.
Contract Type
agreement
Plymouth MeetingBiotechnologyDescription
INOVIO has announced that its partner, ApolloBio, has achieved positive topline results from the Phase 3 trial of VGX-3100, a DNA immunotherapy for cervical dysplasia. These results are expected to support ApolloBio's future regulatory submission in China.
Quick answer
INOVIO Partners with ApolloBio to Submit Regulatory Filing for VGX-3100 Following Successful Phase 3 Trial. (May 22, 2026). Inovio is based in Plymouth Meeting, Pennsylvania, United States.
- What agreement did Inovio announce on May 22, 2026?
- INOVIO has announced that its partner, ApolloBio, has achieved positive topline results from the Phase 3 trial of VGX-3100, a DNA immunotherapy for cervical dysplasia. These results are expected to support ApolloBio's future regulatory submission in China.
- What does Inovio do?
- INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases.
- Where is Inovio based?
- Inovio is based in Plymouth Meeting, Pennsylvania, United States.
Source: Fundz verified event record.
Related People
Inovio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.